Symbiosis Pharmaceutical Services is a contract manufacturing organisation (CMO) that specialises in the GMP manufacture and sterile fill/finish of vials for clinical trials and low-volume commercial supply. Regulatory compliance, technical capability and operational flexibility are at its core. Manufacturing takes place in a purpose-built MHRA-licensed and FDA approved facility, enabling the CMO to handle products that require aseptic liquid filling and lyophilisation for a range of complex biologics, viral vectors for use in gene therapies and small molecule drugs. Offering fast access to manufacturing slots and accelerated release of drug product, Symbiosis is primed to meet demand for small-scale, fast-turnaround drug product manufacturing, while maintaining regulatory compliance to the highest standards. Symbiosis specialises in the sterile fill/finish of biologic and small molecule products into vials, which are either liquid or lyophilised formulations. Capabilities include the ability to handle and fill antibodies, proteins, peptides, nucleic acids, cytotoxic, cytostatic and highly potent APIs including ADCs along with conventional small molecules. Symbiosis saves our clients invaluable development time. With short lead times to manufacture and faster release of sterile drug product, we get you into phase I/II quickly. Our focus is service excellence through flexibility, responsiveness and timeliness. If you need a drug filled aseptically, come and speak with Symbiosis...we will exceed your expectations.
View Top Employees from Symbiosis Pharmaceutical ServicesWebsite | http://www.symbiosis-pharma.com |
Revenue | $7 million |
Funding | $1.2 million |
Employees | 121 (102 on RocketReach) |
Founded | 2011 |
Address | Scion House, Stirling Innovation Park, Stirling, Scotland FK9 4NF, GB |
Phone | +44 1786 220000 |
Technologies |
JavaScript,
HTML,
Twitter
+16 more
(view full list)
|
Industry | Biotechnology Research, Drug Stores & Pharmacies, Biopharma, Retail, Biotechnology, Health Care, Science and Engineering |
Web Rank | 8 Million |
Keywords | Small Molecule Drug Discovery, Aseptic Fill Finish, Lyophilization, Viral Vector Manufacturing |
Competitors | Avara Pharmaceutical Services, CoreRx, Inc., DELPHARM GAILLARD, LSNE Contract Manufacturing, Mikart, LLC |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies |
Looking for a particular Symbiosis Pharmaceutical Services employee's phone or email?
The Symbiosis Pharmaceutical Services annual revenue was $7 million in 2024.
Colin MacKay is the Founder and Chief Executive of Symbiosis Pharmaceutical Services.
102 people are employed at Symbiosis Pharmaceutical Services.
Symbiosis Pharmaceutical Services is based in Stirling, Scotland.
The NAICS codes for Symbiosis Pharmaceutical Services are [3254, 32541, 325, 32].
The SIC codes for Symbiosis Pharmaceutical Services are [28, 283].